AOXG — Aoxing Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Aoxing Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2012 June 30th	2013 June 30th	C2014 June 30th	C2015 June 30th	C2016 June 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-Q	10-Q	10-Q
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.68	4.01	2.33	5.37	6.91
Net Total Accounts Receivable
Net Total Receivables	2.8	2.84	3.89	5.85	11.2
Total Inventory
Prepaid Expenses
Total Current Assets	9.52	11.9	10.9	21.1	26.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	27	26.9	26.4	28.7	25.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	45.1	39.7	38.1	53	56.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.6	21.7	34.2	41.2	37.8
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	23.2	34.1	40.6	41.8	37.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	21.9	5.67	-2.51	11.2	19.1
Total Liabilities & Shareholders' Equity	45.1	39.7	38.1	53	56.2
Total Common Shares Outstanding